[{"notes_id":"1_311","category":"3","subcategory":"1","title":"Gynaecomastia","body":"Gynaecomastia describes an abnormal amount of breast tissue in males and is usually caused by an increased oestrogen:androgen ratio. It is important to differentiate the causes of galactorrhoea (due to the actions of prolactin on breast tissue) from those of gynaecomastia<br \/><br \/><div class=\"container\"><div class=\"row\"><div class=\"col-md-3\"><a href=\"https:\/\/d32xxyeh8kfs8k.cloudfront.net\/images_Passmedicine\/pdd983b.jpg\" data-fancybox=\"gallery\" data-caption=\"An example of gynaecomastia. There is a slight asymmetry in terms of the affected breast tissue\"><img  class=\"img-thumbnail mx-auto d-block\" style=\"max-height:150px;margin-bottom:10px;\" src=\"https:\/\/d32xxyeh8kfs8k.cloudfront.net\/images_Passmedicine\/pdd983.jpg\" alt=\"\" \/><\/a><\/div><\/div><\/div><br \/>Causes of gynaecomastia<br \/><ul><li>physiological: normal in puberty<\/li><li>syndromes with androgen deficiency: Kallman's, Klinefelter's<\/li><li>testicular failure: e.g. mumps<\/li><li><span class=\"concept\" data-cid=\"3373\">liver disease<\/span><\/li><li><span class=\"concept\" data-cid=\"10785\">testicular cancer e.g. seminoma secreting hCG<\/span><\/li><li>ectopic tumour secretion<\/li><li>hyperthyroidism<\/li><li>haemodialysis<\/li><li>drugs: see below<\/li><\/ul><br \/>Drug causes of gynaecomastia<br \/><ul><li>spironolactone (most common drug cause)<\/li><li>cimetidine<\/li><li><span class=\"concept\" data-cid=\"3654\">digoxin<\/span><\/li><li>cannabis<\/li><li>finasteride<\/li><li>GnRH agonists e.g. <span class=\"concept\" data-cid=\"10952\">goserelin<\/span>, buserelin<\/li><li>oestrogens, anabolic steroids<\/li><\/ul><br \/>Very rare drug causes of gynaecomastia<br \/><ul><li>tricyclics <\/li><li>isoniazid<\/li><li>calcium channel blockers<\/li><li>heroin<\/li><li>busulfan<\/li><li>methyldopa<\/li><\/ul>","notes_hash":"420f3b0341f96347ca7faec403d91ae5","knowledge_graph_node_id_link":10052,"links":"","media":"","concepts_for_notes":{"10952":{"concept_text":"GnRH agonists (e.g. goserelin) used in the management of prostate cancer may result in gynaecomastia","concept_percentile":"70"}},"category_name":"Endocrinology \/ Metabolic","subcategory_name":"Endocrinology","comment_count":7},"",[]]